JAK3 and neoplasm: Recent studies have further revealed the involvement of JAK3 in tumors immune evasion and microenvironmental crosstalk, suggesting that JAK3-targeted therapy could not only suppress oncogenic signalling but also restore anti-tumor immunity [11,12].